Anders Kvanta

Bevacizumab for macular edema in central retinal vein occlusion: a prospective, randomized, double-masked clinical study.

Subthreshold transpupillary thermotherapy reduces experimental choroidal neovascularization in the mouse without collateral damage to the neural retina.

Delayed inflammation-associated corneal neovascularization in MMP-2-deficient mice.

Choroidal biopsies for intraocular tumors of indeterminate origin.

Photodynamic therapy of experimental choroidal neovascularization in the mouse.

Angiomotin regulates endothelial cell migration during embryonic angiogenesis.

Involvement of purinergic P2 receptors in experimental retinal neovascularization.

Visual improvement in central retinal vein occlusion (CRVO) following intravitreal injections of bevacizumab (Avastin(®) ).

Intravitreal bevacizumab in central retinal vein occlusion: 18-month results of a prospective clinical trial.

Benefit from bevacizumab for macular edema in central retinal vein occlusion: twelve-month results of a prospective, randomized study.

Stem cell-based treatment in geographic atrophy: promises and pitfalls.

Seasonality and incidence of central retinal vein occlusion in Sweden: a 6-year study.

Xeno-Free and Defined Human Embryonic Stem Cell-Derived Retinal Pigment Epithelial Cells Functionally Integrate in a Large-Eyed Preclinical Model.

Vitamin D Deficiency in Patients with Central Retinal Vein Occlusion: A Case Control Study.

Gene Transfer of Prolyl Hydroxylase Domain 2 Inhibits Hypoxia-inducible Angiogenesis in a Model of Choroidal Neovascularization.

Integration of Subretinal Suspension Transplants of Human Embryonic Stem Cell-Derived Retinal Pigment Epithelial Cells in a Large-Eyed Model of Geographic Atrophy.

A novel in vivo model of puncture-induced iris neovascularization.

Efficacy of a Fatty Acids Dietary Supplement in a Polyethylene Glycol-Induced Mouse Model of Retinal Degeneration.

A model to study complement involvement in experimental retinal degeneration.